SNA
52
2
ORCL
32
3
DTE
43
3
ADSK
57
-2
NAVI
36
9
ITW
40
3
KR
49
-3
FTI
84
3
PM
52
-4
FSLR
57
-6
NSC
64
2
CME
49
-3
CRM
52
2
AES
45
-4
RRC
58
6
COP
47
2
EQT
65
8
APA
52
2
TXN
69
4
FRT
58
2
SNA
52
2
ORCL
32
3
DTE
43
3
ADSK
57
-2
NAVI
36
9
ITW
40
3
KR
49
-3
FTI
84
3
PM
52
-4
FSLR
57
-6
NSC
64
2
CME
49
-3
CRM
52
2
AES
45
-4
RRC
58
6
COP
47
2
EQT
65
8
APA
52
2
TXN
69
4
FRT
58
2
Financhill
Back

Axsome Therapeutics, Inc. 10K Form

Buy
59

AXSM
Axsome Therapeutics, Inc.

Last Price:
$148.01
Seasonality Move:
21.92%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive AXSM News And Ratings

See the #1 stock for the next 7 days that we like better than AXSM

AXSM Financial Statistics

Sales & Book Value

Annual Sales: $385.7M
Cash Flow: $988K
Price / Cash Flow: 0
Annual Sales: $1.47
Price / Book: 101.07

Profitability

EPS (TTM): -4.67340
Net Income (TTM): $-229.5M
Gross Margin: $344.4M
Return on Equity: -327.97%
Return on Assets: -37.81%

Axsome Therapeutics, Inc. Earnings Forecast

Key Axsome Therapeutics, Inc. Financial Ratios

  • The Gross Profit Margin over the past 5 years for AXSM is 89.30%.
  • The Selling, General & Administrative Expenses for AXSM have been equal to 106.65% of Gross Profit Margin.
  • The Research & Development expenses have been 48.37% of Revenue.
  • The Net Earning history of AXSM is -74.47% of Total Revenues.
  • Per Share Earnings over the last 12 years have been positive in 2 years.

Axsome Therapeutics, Inc. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: AXSM
CUSIP: 05464T
Website: axsome.com

Debt

Debt-to-Equity Ratio: 2.96
Current Ratio: 1.57
Quick Ratio: 1.45

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 566.63

AXSM Technical Analysis vs Fundamental Analysis

Buy
59
Axsome Therapeutics, Inc. (AXSM) is a Buy

Is Axsome Therapeutics, Inc. a Buy or a Sell?